Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly
WEARVALLEYMERCURY
CFOTO | Future Publishing | Getty Pictures As its Covid gains evaporate, Pfizer desires a bit of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental weight problems capsule, danuglipron, shall be essential in figuring out how aggressive the corporate will be towards the area’s dominant gamers Eli Lilly and Novo … Read more